A Stratified Sickle Event Randomized Trial (ASSERT)

NCT00102791 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

297

Enrollment

INDUSTRY

Sponsor class

Stopped Because of the low probability of achieving the primary endpoint.

Conditions

Sickle Cell Disease

Interventions

DRUG: ICA-17043

Sponsor

Icagen

Collaborators

[object Object]